ＫＲＡＳ Ｇ１２Ｃ阻害剤化合物の新たな結晶形態

Japanese Patent JP2023547194

A

ＫＲＡＳ Ｇ１２Ｃ阻害剤化合物の結晶形態及びそれらの調製の方法が提供される。さらに、前記結晶形態及び少なくとも１種の薬学的に許容できる賦形剤を含む医薬組成物が提供される。医薬組成物は、特に癌及びＫＲＡＳ Ｇ１２Ｃ－変異癌の治療のための医薬品として使用できる。

WO/2009/110557	AZO PIGMENT COMPOSITION, PROCESS FOR PRODUCTION OF THE COMPOSITION, DISPERSIONS CONTAINING THE COMPOSITION, COLORED COMPOSITIONS AND JET PRINTING INK
JP6577012	Benzimidazole derivative as an ERBB tyrosine kinase inhibitor for the treatment of cancer
WO/2008/148302	ARENE CONNECTED POLYAMINE MACRORING DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF

Riu, Bo
Cotesta, Simona
ge, hen
Gerspacher, Marc
Leblanc, Catherine
L'Orciois, Edwidge Lillian Jenne
mccauer, liner
Ma, robert
Meister, Tanya
Mura, Christophe
Rigolier, Pascal
Schneider, Nadine
Stutz, Stefan
Faupel, Andrea
Warin, Nicholas
wilken, liner
Xue, Lijun
Rosach, Marie Anne
Strang, Ross Sinclair

JP2023525961A

November 09, 2023

October 29, 2021

Click for automatic bibliography generation  

Novartis Age

C07D403/14; A61K31/416; A61P35/00; A61P43/00

Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Saori Oga

Previous Patent: Reusable hub assembly for abrasive articles

Next Patent: Europium(III) complexes as pH sensors